CRISPR

CRISPR1-gpr161a

ID
ZDB-CRISPR-211118-6
Name
CRISPR1-gpr161a
Previous Names
  • CRISPR1-gpr161ab
  • CRISPR1-gpr161b
Target
Sequence
5' - AGGACAGCCAGGACACCG - 3'
ZFIN BLAST NCBI BLAST Ensembl
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
ml200 gpr161a
Expression
Gene expression in Wild Types + CRISPR1-gpr161a
No data available
Phenotype
Phenotype resulting from CRISPR1-gpr161a
No data available
Phenotype of all Fish created by or utilizing CRISPR1-gpr161a
Phenotype Fish Conditions Figures
somite ptch2 expression increased amount, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 3 with image from Tschaikner et al., 2021
pharynx malformed, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 1 with image from Tschaikner et al., 2021
spinal cord neural tube ventral region olig2 expression increased amount, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
somite lateral surface has extra parts of type slow muscle cell, exacerbated gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
somite has extra parts of type muscle pioneer, abnormal gpr161bml201/ml201; gpr161aml200/ml200 control Fig. 4 with image from Tschaikner et al., 2021
mandibular arch skeleton malformed, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 1 with image from Tschaikner et al., 2021
somite has number of muscle pioneer, ameliorated gpr161bml201/ml201; gpr161aml200/ml200 chemical treatment by environment: forskolin Fig. 4 with image from Tschaikner et al., 2021
inner ear malformed, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 1 with image from Tschaikner et al., 2021
neural tube smoothened signaling pathway increased process quality, exacerbated gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
spinal cord neural tube ventral region nkx2.2a expression increased distribution, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 3 with image from Tschaikner et al., 2021
whole organism nkx2.2b expression increased amount, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
somite lateral surface has extra parts of type slow muscle cell, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image,  Fig. 3 with image from Tschaikner et al., 2021
somite lateral surface has number of slow muscle cell, ameliorated gpr161bml201/ml201; gpr161aml200/ml200 chemical treatment by environment: forskolin Fig. 4 with image from Tschaikner et al., 2021
spinal cord neural tube ventral region olig2 expression increased distribution, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 3 with image from Tschaikner et al., 2021
whole organism ptch2 expression increased amount, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
somite has extra parts of type muscle pioneer, exacerbated gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
whole organism nkx6.1 expression increased amount, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
somite ptch2 expression increased distribution, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 3 with image from Tschaikner et al., 2021
spinal cord neural tube ventral region nkx2.2a expression increased amount, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
somite ptch2 expression increased amount, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
olfactory pit decreased size, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 1 with image from Tschaikner et al., 2021
embryonic camera-type eye morphogenesis decreased process quality, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 1 with image from Tschaikner et al., 2021
retina malformed, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 1 with image from Tschaikner et al., 2021
spinal cord neural tube ventral region olig2 expression increased amount, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 3 with image from Tschaikner et al., 2021
somite has extra parts of type muscle pioneer, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image,  Fig. 3 with image from Tschaikner et al., 2021
spinal cord neural tube ventral region nkx2.2a expression increased distribution, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
immature eye malformed, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 1 with image from Tschaikner et al., 2021
pharynx open, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 1 with image from Tschaikner et al., 2021
inner ear lacks all parts of type dorsolateral septum, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 1 with image from Tschaikner et al., 2021
inner ear morphogenesis decreased process quality, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 1 with image from Tschaikner et al., 2021
spinal cord neural tube ventral region olig2 expression increased distribution, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
whole organism pax7a expression decreased amount, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
somite lateral surface has extra parts of type slow muscle cell, abnormal gpr161bml201/ml201; gpr161aml200/ml200 control Fig. 4 with image from Tschaikner et al., 2021
whole organism gli1 expression increased amount, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
somite malformed, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 1 with image from Tschaikner et al., 2021
somite ptch2 expression increased distribution, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
embryonic viscerocranium morphogenesis decreased process quality, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 1 with image from Tschaikner et al., 2021
neural tube smoothened signaling pathway increased process quality, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 2 with image from Tschaikner et al., 2021
spinal cord neural tube ventral region nkx2.2a expression increased amount, abnormal gpr161bml201/ml201; gpr161aml200/ml200 standard conditions Fig. 3 with image from Tschaikner et al., 2021
somite lacks parts or has fewer parts of type muscle pioneer, abnormal gpr161bml201/+; gpr161aml200/+; smohi1640Tg/hi1640Tg standard conditions Fig. 3 with image from Tschaikner et al., 2021
somite lateral surface lacks parts or has fewer parts of type slow muscle cell, abnormal gpr161bml201/+; gpr161aml200/+; smohi1640Tg/hi1640Tg standard conditions Fig. 3 with image from Tschaikner et al., 2021
somite Ab12-prox1 labeling absent, abnormal gpr161bml201/+; gpr161aml200/+; smohi1640Tg/hi1640Tg standard conditions Fig. 3 with image from Tschaikner et al., 2021
somite ab1-eng labeling absent, abnormal gpr161bml201/+; gpr161aml200/+; smohi1640Tg/hi1640Tg standard conditions Fig. 3 with image from Tschaikner et al., 2021
somite ptch2 expression increased amount, abnormal gpr161bml201/ml201; gpr161aml200/ml200; smohi1640Tg/hi1640Tg standard conditions Fig. 3 with image from Tschaikner et al., 2021
spinal cord neural tube ventral region nkx2.2a expression absent, abnormal gpr161bml201/ml201; gpr161aml200/ml200; smohi1640Tg/hi1640Tg standard conditions Fig. 3 with image from Tschaikner et al., 2021
somite lateral surface has extra parts of type slow muscle cell, abnormal gpr161bml201/ml201; gpr161aml200/ml200; smohi1640Tg/hi1640Tg standard conditions Fig. 3 with image from Tschaikner et al., 2021
spinal cord neural tube ventral region olig2 expression increased distribution, abnormal gpr161bml201/ml201; gpr161aml200/ml200; smohi1640Tg/hi1640Tg standard conditions Fig. 3 with image from Tschaikner et al., 2021
somite ptch2 expression increased distribution, abnormal gpr161bml201/ml201; gpr161aml200/ml200; smohi1640Tg/hi1640Tg standard conditions Fig. 3 with image from Tschaikner et al., 2021
spinal cord neural tube ventral region olig2 expression increased amount, abnormal gpr161bml201/ml201; gpr161aml200/ml200; smohi1640Tg/hi1640Tg standard conditions Fig. 3 with image from Tschaikner et al., 2021
somite has extra parts of type muscle pioneer, abnormal gpr161bml201/ml201; gpr161aml200/ml200; smohi1640Tg/hi1640Tg standard conditions Fig. 3 with image from Tschaikner et al., 2021
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.